Showing 1 - 10 of 14
. Allowing for price cap regulation, we show that the negative effect on generic entry can be reversed, and that reference …
Persistent link: https://www.econbiz.de/10013024341
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. First … prices. We show that the effects of price regulation crucially depend on whether the producer faces competition from parallel … imports. While parallel imports improve the bargaining position of the pharmacy, price regulation counteracts this effect and …
Persistent link: https://www.econbiz.de/10013060442
This paper studies the diffusion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries...
Persistent link: https://www.econbiz.de/10014158749
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10013139185
We study the incentives for hospitals to provide quality and expend cost-reducing effort when their budgets are soft, i.e., the payer may cover deficits or confiscate surpluses. The basic set up is a Hotelling model with two hospitals that differ in location and face demand uncertainty, where...
Persistent link: https://www.econbiz.de/10013108158
Using a spatial competition framework with three ex ante identical hospitals, we study the effects of a hospital merger on quality, price and welfare. The merging hospitals always reduce quality, but the non-merging hospital responds by reducing quality if prices are fixed and increasing quality...
Persistent link: https://www.econbiz.de/10013083187
We study the impact of exposing hospitals in a National Health Service (NHS) to non-price competition by exploiting a patient choice reform in Norway in 2001. The reform facilitates a difference-in-difference research design due to geographical variation in the scope for competition. Using rich...
Persistent link: https://www.econbiz.de/10012906335
Using a spatial competition framework with three ex ante identical firms, we study the effects of a horizontal merger on quality, price and welfare. The merging firms always reduce quality. They also increase prices if demand responsiveness to quality is sufficiently low. The non-merging firm,...
Persistent link: https://www.econbiz.de/10013059116
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharmaceutical market. For given prices, RP increases generic firms' expected profit, but since RP also stimulates price competition, the impact on generic entry is theoretically ambiguous. In order to...
Persistent link: https://www.econbiz.de/10013021208
We study the effect of competition on quality in markets such as health care, long-term care and education, when providers choose both prices and quality in a setting of spatial competition. We offer a novel mechanism whereby competition leads to lower quality. This mechanism relies on two key...
Persistent link: https://www.econbiz.de/10014171074